Another marker that was significantly elevated in advanced liver fibrosis was alpha-fetoprotein (AFP) (P = 0.0019), which has previously been shown to be elevated in HCV patients with cirrhosis and is a clinical marker of HCC [28], [29], although none of our patients had been diagnosed with HCC at present. The gene discussed is AFP; the disease is hepatocellular carcinoma.